Arrowhead Pharmaceuticals, Inc. · NASDAQ:ARWR

Sarepta Therapeutics, Inc. reported a 9.50% stake in Arrowhead Pharmaceuticals, Inc. (Schedule 13D)

Event Feb 7, 2025 · Filed Feb 14, 2025

Sarepta Therapeutics, Inc. reported a 9.50% stake in Arrowhead Pharmaceuticals, Inc., 11,926,301 shares, with active intent on Feb 7, 2025. Filed Feb 14, 2025 (Schedule 13D).

Stake
9.50%
Shares
11,926,301
Intent
Active
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Sarepta Therapeutics, Inc.9.50%11,926,301
Sarepta Therapeutics Investments, Inc.9.50%11,926,301

Source

View original at SEC

Related